Jacob P. Laubach

Resolving the daratumumab interference with blood compatibility testing

J. Laubach, P. Richardson, B. Chapuy, 2015, Transfusion.

The potential benefits of participating in early‐phase clinical trials in multiple myeloma: long‐term remission in a patient with relapsed multiple myeloma treated with 90 cycles of lenalidomide and bortezomib

J. Laubach, P. Richardson, C. Mitsiades, 2012, European journal of haematology.

Outcomes in patients with relapsed or refractory multiple myeloma in a phase I study of everolimus in combination with lenalidomide

K. Anderson, N. Munshi, J. Laubach, 2014, British journal of haematology.